Overview
Lydia Meder practices practicing medicine in Bayreuth, Germany.
Ms. Meder is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Metastases, Lung Cancer, and Lung Adenocarcinoma.
She is actively involved in clinical research, co-authoring 33 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lydia Meder
Is Lydia Meder a top-rated expert for Small Cell Lung Cancer (SCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Lydia Meder is classified as an Advanced expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lydia Meder participate in research or clinical trials?
Yes. Lydia Meder has published 33 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Lydia Meder's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung MetastasesMs. Meder isAdvanced. Learn about Lung Metastases.
- Small Cell Lung Cancer (SCLC)Ms. Meder isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- EGFR Positive Lung CancerMs. Meder isExperienced. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaMs. Meder isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerMs. Meder isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Meder isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- RetinoblastomaMs. Meder isExperienced. Learn about Retinoblastoma.
- Vitamin D DeficiencyMs. Meder isExperienced. Learn about Vitamin D Deficiency.